Form 4: Teladoc Health Director Jason Evans Converts Restricted Stock Units to Common Shares

Sentiment:

Insider Transaction Report


Teladoc Health, Inc. Director Jason Eric Evans converted 1,016 restricted stock units into common stock on June 20, 2025, as part of a pre-planned vesting schedule.

Summary

  • Jason Eric Evans, a Director at Teladoc Health, Inc. (TDOC), reported a transaction on June 20, 2025.
  • The transaction involved the conversion of 1,016 Restricted Stock Units (RSUs) into an equal number of shares of Teladoc Health common stock.
  • Following this transaction, Mr. Evans directly beneficially owns 7,113 shares of Common Stock.
  • Additionally, Mr. Evans directly beneficially owns 5,082 Restricted Stock Units.
  • The RSUs converted were part of a grant of 12,195 RSUs awarded on September 20, 2023, with a vesting schedule of one-third on the first anniversary of the grant date and the remainder in eight substantially equal quarterly installments thereafter.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction (conversion of RSUs to common stock) as part of a pre-planned vesting schedule. It does not contain information that would significantly alter the company's financial outlook or operational status, thus indicating a neutral sentiment.

Future Outlook

The document does not contain forward-looking statements or guidance beyond the pre-determined vesting schedule of the reported restricted stock units.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction, specifically the conversion of restricted stock units into common shares. Such transactions are common for executives and directors as part of their compensation packages and do not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: This transaction represents a routine increase in the number of common shares held by a director, aligning his interests with shareholders through direct equity ownership. It does not dilute existing shares beyond what was anticipated by the RSU grant.

Next Steps

  • The remaining 5,082 Restricted Stock Units held by Mr. Evans are expected to vest in eight substantially equal quarterly installments following the first anniversary of the September 20, 2023 grant date.

Key Dates

DateDescription
09/20/2023Date when Jason Eric Evans was granted 12,195 restricted stock units.
06/20/2025Date of the reported transaction where 1,016 restricted stock units were converted to common stock.
06/23/2025Date the Form 4 filing was signed by Adam C. Vandervoort, Attorney-in-Fact for Jason Eric Evans.

Keywords

Teladoc Health, TDOC, SEC Form 4, Insider Transaction, Restricted Stock Units, Common Stock, Director, Equity Conversion, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.